Page 1 of Clinical Trials for Lenalidomide, 454 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients
Last Updated: December 28, 2011
Condition(s): Multiple Myeloma
2
Recruiting
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia Subjects ≥ 65 Years of Age
Last Updated: May 1, 2012
Condition(s): Acute Myeloid Leukemia; Acute Myelogenous Leukemia
3
Recruiting
Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma
Last Updated: September 8, 2011
Condition(s): Relapsed Multiple Myeloma
4
Active, not recruiting
Combination Therapy Using Lenalidomide (Revlimid)- Low Dose Dexamethasone and Rituximab for Treatment of Rituximab-Resistant, Non-Aggressive B-Cell Lymphomas
Last Updated: December 19, 2011
Condition(s): Follicular Lymphoma; Marginal Zone B-Cell Lymphoma; MALT Lymphoma; Lymphoma of Mucosa-Associated Lymphoid Tissue; Lymphoma, Small Lymphocytic; Waldenstrom Macroglobulinemia; Mantle-Cell Lymphoma
5
Recruiting
Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT)
Last Updated: February 14, 2012
Condition(s): Relapsed or Refractory Multiple Myeloma; Kahler; Revlimid; Endoxan; Prednisone
6
Not yet recruiting
Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy
Last Updated: December 28, 2011
Condition(s): Multiple Myeloma
7
Completed
Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)
Last Updated: February 18, 2011
Condition(s): Cutaneous Lupus Erythematosus (CLE)
8
Recruiting
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
Last Updated: April 23, 2012
Condition(s): Multiple Myeloma; Plasma Cell Neoplasm
9
Recruiting
Use of Thalidomide, Lenalidomide, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients
Last Updated: March 19, 2012
Condition(s): Multiple Myeloma
10
Recruiting
Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age
Last Updated: April 18, 2012
Condition(s): Chronic Lymphocytic Leukemia; Leukemia
11
Active, not recruiting
Lenalidomide in Relapsed or Refractory Classical Hodgkin Lymphoma
Last Updated: May 18, 2012
Condition(s): Hodgkin Disease
12
Active, not recruiting
Lenalidomide Dose Escalation Combined With Rituximab/Fludarabine in Untreated CLL
Last Updated: May 9, 2011
Condition(s): Leukemia, Lymphocytic, Chronic, B-Cell
13
Completed
Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality
Last Updated: April 12, 2011
Condition(s): Myelodysplastic Syndromes
14
Recruiting
Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance After Autologous Stem Cell Transplantation
Last Updated: March 23, 2012
Condition(s): Multiple Myeloma
15
Active, not recruiting
Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer
Last Updated: May 14, 2012
Condition(s): Castrate-Resistant Prostate Cancer
16
Recruiting
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
Last Updated: May 4, 2012
Condition(s): Advanced Cancers
17
Active, not recruiting
Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas
Last Updated: May 2, 2011
Condition(s): Metastatic Pancreatic Cancer
18
Completed
A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
Last Updated: September 26, 2011
Condition(s): Relapsed or Refractory Multiple Myeloma
19
Terminated
Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma
Last Updated: April 10, 2006
Condition(s): Ovarian Cancer
20
Completed
Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma
Last Updated: August 31, 2009
Condition(s): Melanoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Lenalidomide

Page 1 of Clinical Trials for Lenalidomide, 454 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About